SCHEMBL7966736

SCHEMBL7966736

Cc1cccc(OC[C@H]2CO2)c1C

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.74
GLA P06280 1/20 0.74
TP53 P04637 3/20 0.53
TSHR P16473 3/20 0.53
HIF1A Q16665 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
CYP3A4 P08684 1/20 0.53
TDP1 Q9NUW8 1/20 0.50
HTR1B P28222 1/20 0.49
POLB P06746 1/20 0.45
PKM P14618 1/20 0.44
MAPT P10636 5/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
HPGD P15428 2/20 0.44
CYP1A2 P05177 1/20 0.44
PPARG P37231 1/20 0.44
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
HTR1A P08908 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7966731 1.00 ALDH1A1 (0.74) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL3956224 1.00 ALDH1A1 (0.74) ALDH1A1GLATP53TSHRHIF1A
Ethane SCHEMBL8645440 0.98 ALDH1A1 (0.72) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL732840 0.93 ALDH1A1 (0.73) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL179950 0.85 ALDH1A1 (1.00) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL2527037 0.85 ALDH1A1 (1.00) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL29498775 0.85 ALDH1A1 (1.00) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL29424137 0.85 ALDH1A1 (1.00) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL2525751 0.85 ALDH1A1 (1.00) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL11591476 0.85 ALDH1A1 (0.63) ALDH1A1GLATP53TSHRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242450-B1 SUBSTITUTED PIPERIDINES ELI LILLY AND COMPANY 2001-06-05 US disclosed
WO-2000006082-A2 TREATMENT OF ANXIETY DISORDERS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
WO-2000006166-A1 5-HT1F ANTAGONISTS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed
EP-0976747-A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed